I don't consider 30% to be too rare.
Another claim with no evidence, reasoning, or data to help the interested mind see what, why or how the claim came to be a belief. I'm not dissin a one line reply with no value, (I've made my share), but in a thread about facts, myth, and knowing what is true, it isn't advancing either skepticism, or knowledge.
I'm trying to find a paper right now. I can show you the genome of HIV-I, HIV-II, and SIV all on the same page. They are very similar.
And I have been looking for this link for a day now. I must have a thousand HIV links. Grr...
That's interesting. What's the lethality? What's the latency? What's the course of the disease?No time to play today, but for anyone who doubts that a retrovirus can cause disease, here are a few facts. No doubt about it at all.
This is another reason that most people accept that HIV causes AIDS.
The SIV strains, endemic in African monkeys, which are almost exactly the same as HIV, doesn't make them sick, but causes AIDS in Asian
species of primates, such as the stump tailed macaque, and the
rhesus macaque.
The two kinds of HIV causing people to become ill, look almost exactly like SIV, and HIV-2 is very similar to a SIV. If it had been found in Monkeys first, it would be called a SIV. (In fact, it was, several times)
This experiment has been done over and over. There is no doubt that a new SIV introduced into a primate that has no resistance to it, can cause AIDS like symptoms.
http://www.sciencemag.org/cgi/content/abstract/230/4721/71The T-cell tropic retrovirus of macaque monkeys STLV-III has morphologic, growth, and antigenic properties indicating that it is related to HTLV-III/LAV, the etiologic agent of the acquired immune deficiency syndrome (AIDS) in humans. Four of six rhesus monkeys died within 160 days of STLV-III inoculation with a wasting syndrome, opportunistic infections, a primary retroviral encephalitis, and immunologic abnormalities including a decrease in T4+ peripheral blood lymphocytes. These data show that an immunodeficiency syndrome can be produced experimentally in a nonhuman primate by an agent from the HTLV-III/LAV group of retroviruses.
http://yarchive.net/med/lentiviruses.htmlEven closer to HIV (genetically and antigenically), and still
identical in appearance, are the SIV viruses (simian immunodefic-
iency viruses). These viruses are native to African monkeys,
which they infect chronically but apparently do not cause disease
in. These viruses, however, do cause AIDS when given to Asian
species of primates, such as the stump tailed macaque, and the
rhesus macaque. SIV viruses infect macrophages and CD4 cells
selectively, just as the HIV strains do. The syndrome they cause
in Asian monkeys includes lymphadenopathy, wasting, lymphoma,
lymphocyte depletion, and many opportunistic infections such as
Pneumocystis pneumonia, CMV retinitis, chronic cryptosporidia
diarrhea, and invasive candidiasis.
http://www.aidsonline.com/pt/re/aid...hpf7CVFvRccGYD36!1683421839!181195628!8091!-1The viral loads were compared by ANOVA during the acute infection period of 7-21 days post-inoculation. The viral loads were significantly higher during the acute peak phase in Ind Rh than in Ch Rh (Table 2). Ind Rh viral loads varied from 1.5 × 107 to 2.2 × 108 compared with 3.5 × 106 to 6.0 × 107 copies/ml for the Ch Rh (P < 0.0013). The kinetics of the plasma viral loads were similar in Ind and Ch Rh, each with a decline beginning at about 14 days and reaching a steady state by about 60 days. The differences in steady-state viral loads were measured from 35 to 120 days post-infection and were also significantly higher in the Ind Rh group (Table 2). This comparison was not carried beyond 120 days because of the AIDS-related deaths of two of the four Ind Rh. However, 9 of the 10 Ch Rh were healthy and free of AIDS throughout the study. One Ch Rh, J304, which had the highest viral load, had marked splenomegaly, generalized lymphadenopathy, bouts of diarrhea and moderate anemia with below normal numbers of reticulocytes in the peripheral blood.
http://jvi.asm.org/cgi/content/abstract/72/12/10281To determine if a specific pathogenic threshold of plasma viral RNA could be defined irrespective of virus strain, RNA levels in the plasma of more than 50 infected rhesus macaques (Macaca mulatta) were measured. Animals were inoculated intravenously with either simian immunodeficiency virus (SIV) or simian-human immunodeficiency virus (SHIV) strains of known pathogenic potential (SIV8980, SIVsmm-3, SIVmac32H/J5, SIVmac32H/1XC, reverse transcriptase-SHIV, SHIV89.6p) or with attenuated strains (SHIVW6.1D, SHIVsf13, SHIVhan-2, SIVmacDelta nef, SHIVsf33). In animals inoculated with nonpathogenic strains, shortly after the primary peak of viremia viral RNA levels declined and remained below 104 RNA equivalents/ml of plasma between 6 and 12 weeks postinoculation. Animals infected with documented pathogenic strains maintained viral RNA levels higher than 105 RNA equivalents/ml of plasma. In animals infected with strains with low virulence, a decline in plasma RNA levels was observed, but with notable individual variation.
Damn. You might almost think some of those were created in a lab or something.
The SHIVs are, what of it?SIV8980,
SIVsmm-3,
SIVmac32H/J5,
SIVmac32H/1XC,
reverse transcriptase-SHIV,
SHIV89.6p
SHIVW6.1D,
SHIVsf13,
SHIVhan-2,
SIVmacDelta nef,
SHIVsf33
Damn. You might almost think some of those were created in a lab or something.
This collection of articles from Nature seeks to highlight the considerable progress that has been made over the past couple of years in understanding the interplay between the virus and the immune system of infected individuals at the molecular and cellular levels. The immunopathogenic consequences of viral infection have been elucidated (pages 17, 22 and 44), the cellular determinants of transmission have been characterized (pages 10 and 26), the three-dimensional structures of crucial cellular and viral proteins have been deduced (pages 2, 37 and 49), and a strategy has been developed to circumvent pre-existing immunity to a potential vaccine-delivery vector (page 31).
Despite global efforts to improve access to treatment, existing HIV/AIDS therapies are still not reaching the majority of those in need. This Nature collection draws together recent molecular and cellular studies on the interplay between HIV and the immune system, which are helping to advance the search for an effective vaccine and new drugs to combat the HIV/AIDS epidemic.
How much money did Merck & Co shell out for this supplement?
I've tried to order a print copy of this from them. Twice. Each time they thanked me for ordering their supplement on Nanotechnology in Cancer.Nature is currently making a free supplement available on the subject of HIV/AIDS. Forumites may wish to check it out.
I've tried to order a print copy of this from them. Twice. Each time they thanked me for ordering their supplement on Nanotechnology in Cancer.
![]()
I'll see what arrives in 4 weeks.
If you previously requested a copy of this supplement, but have not
received your copy yet, please fill out the request form again. We
apologize that we encountered a problem with the initial distribution
of the product.
How much money did Merck & Co shell out for this supplement?
No idea.
If you really want to try and find out, do go ahead and contact Nature Publishing Group or Merck & Co directly.
Nature is currently making a free supplement available on the subject of HIV/AIDS. Forumites may wish to check it out.
Hey robinson, you were wondering about vaccination, here's an interesting anti-vaccination piece that also deals with SIV contamination of vaccinations, maybe it's of some help. Link
I know, a lot of it is homeopathy-advocating ****, but it does have some sources, on certain statements, by one of the like 2 speakers in it that appear to have some intellectual capacity.That video has been around for a while. Doesn't quote sources, or focus on science and evidence.
A group of prostitutes thought to be immune to HIV have now become infected, causing dismay to scientists hoping to develop an Aids vaccine.
It was thought that exposure to HIV on a regular basis created immunity, but six Kenyan women previously thought to be resistant are now HIV-positive.
The women are all former prostitutes who have since left the business.
Scientists now think immunity may be reliant on continued exposure - once regular contact with HIV stops, immunity is lost.
Researchers at Oxford University have been monitoring 43 Kenyan prostitutes constantly exposed to HIV who had not been infected.
Sarah Rowland-Jones, a researcher at Oxford University, described the development of HIV in the six women as "dismaying". She added: "This implies that to maintain immunity, you need to have continual exposure."